56
Participants
Start Date
February 28, 2010
Primary Completion Date
May 31, 2010
Study Completion Date
June 30, 2010
Prasugrel
"Prasugrel 10mg tablet administered once daily for 7 days.~After a 1-day to 14-day screening period, participants will receive active treatment with either prasugrel or clopidogrel for 7 days. If a participant has not missed more than 1 dose of study medication and is unable to attend Visit 3 (Washout Day 1) the day after the 7th day of study medication, the participant may take up to an additional 3 days of study medication and proceed to Visit 3 the day after the last dose. Active treatment will be followed by a 1-day to 12-day Washout Period depending on the time to reach both of the exit criteria."
Clopidogrel
"Clopidogrel 75 mg tablet administered once daily for 7 days.~After a 1-day to 14-day screening period, participants will receive active treatment with either prasugrel or clopidogrel for 7 days. If a participant has not missed more than 1 dose of study medication and is unable to attend Visit 3 (Washout Day 1) the day after the 7th day of study medication, the participant may take up to an additional 3 days of study medication and proceed to Visit 3 the day after the last dose. Active treatment will be followed by a 1-day to 12-day Washout Period depending on the time to reach both of the exit criteria."
University of Florida Health Science Center Shands Jacksonville, Jacksonville
Medpace Clinical Pharmacology Unit, Cincinnati
Black Hills Clinical Research Center, Rapid City
Scripps Clinic, La Jolla
Lead Sponsor
Daiichi Sankyo
INDUSTRY